Background Hospitals and providers receive feedback information on how their performance
compares with others, often using funnel plots to detect outliers. These funnel plots typically …

Objectives Reducing the treatment time while increasing the proportion of eligible stroke
patients who receive intravenous tissue plasminogen activator (tPA) has been a priority for …

Objectives To examine door-to-needle time (DNT) trends and the impact of continuous
quality improvement initiatives since thrombolysis became standard of care in Australian …

Background: In patients with acute ischemic stroke, early treatment with recombinant tissue
plasminogen activator (rtPA) improves functional outcome by effectively reducing disability …

Background and Purpose: Improving door-to-needle times (DNTs) for thrombolysis of acute
ischemic stroke patients improves outcomes, but participation in DNT improvement …

Background Hospitals and providers receive feedback information on how their performance
compares with others, often using funnel plots to detect outliers. These funnel plots typically …

Background: In acute ischemic stroke, timely treatment is of utmost relevance. Identification
of delaying factors and knowledge about challenges concerning hospital structures are …

Background In a busy stroke centre in Ireland, care for acute stroke was provided by a
mixture of general physicians. In acute ischaemic stroke, speed is essential for good …

Methods The time frame was divided into two semesters as a new protocol was started at the
beginning of the second semester to ensure a rapid evaluation, imaging, and intravenous …

Intravenous thrombolysis (IVT) plays a prominent role in the treatment of acute ischemic
stroke (AIS). The sooner IVT is administered, the higher the odds of a good outcome …